A systematic review of Australian hospitals' policies on the deactivation of implantable cardioverter defibrillators

Back

ESC Professional Premium Access

A systematic review of Australian hospitals' policies on the deactivation of implantable cardioverter defibrillators

Session: Devices and heart failure: ICD and CRT

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor D. Grose (Melbourne, AU)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Daniel Grose

Royal Melbourne Hospital, Melbourne (Australia)

0 follower

6 more presentations in this session

Efficacy of implantable cardioverter-defibrillator in non-ischemic systolic heart failure in patients with and without chronic kidney disease: an extended follow-up analysis of the DANISH trial

Speaker: Doctor S. N Doi (Copenhagen, DK)

Association between implanted cardioverter-defibrillator and mortality for patients with left ventricular ejection fraction near 35%

Speaker: Assistant Professor J. Wasfy (Boston, US)

Effect of implantable cardioverter-defibrillator in non-ischaemic systolic heart failure according to the Heart Failure Collaboratory Medical Therapy Score: extended follow-up of the DANISH trial

Speaker: Doctor A. Yafasova (Copenhagen, DK)

Left bundle branch area pacing in patients with CRT indication: short-term results & 1-year follow-up

Speaker: Doctor V. Kataria (New Delhi, IN)

Access

Abstract

Slides

Role of fragmented QRS complex in the prognosis of patients undergoing cardiac resynchronization therapy. A new red flag to look for?

Speaker: Doctor C. Rodriguez-Lopez (Madrid, ES)

Access the full session

Devices and heart failure: ICD and CRT

Speakers: Doctor D. Grose, Doctor S. N Doi, Assistant Professor J. Wasfy, Doctor A. Yafasova, Doctor V. Kataria...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources